S. Oresti , F. Salomone , A. Nuccio , F.R. Ogliari , S.T. Riva , L. Mollica , F.M. Venanzi , M. Ferrara , F. Passaretti , L. Papotto , A. Di Lello , A. Bulotta , B. Ricciuti , R. Califano , M. Di Maio , A. Cortellini , V. Torri , M. Cinquini , G. Viscardi , R. Ferrara
{"title":"27P:铂基化疗(CT)对非小细胞肺癌(NSCLC)一线免疫检查点抑制剂(ICI)获得性耐药(AR)的影响:个体患者数据荟萃分析","authors":"S. Oresti , F. Salomone , A. Nuccio , F.R. Ogliari , S.T. Riva , L. Mollica , F.M. Venanzi , M. Ferrara , F. Passaretti , L. Papotto , A. Di Lello , A. Bulotta , B. Ricciuti , R. Califano , M. Di Maio , A. Cortellini , V. Torri , M. Cinquini , G. Viscardi , R. Ferrara","doi":"10.1016/S1556-0864(25)00222-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S28-S29"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"27P: Impact of platinum-based chemotherapy (CT) on acquired resistance (AR) to first-line immunecheckpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC): Individual patient data metanalysis\",\"authors\":\"S. Oresti , F. Salomone , A. Nuccio , F.R. Ogliari , S.T. Riva , L. Mollica , F.M. Venanzi , M. Ferrara , F. Passaretti , L. Papotto , A. Di Lello , A. Bulotta , B. Ricciuti , R. Califano , M. Di Maio , A. Cortellini , V. Torri , M. Cinquini , G. Viscardi , R. Ferrara\",\"doi\":\"10.1016/S1556-0864(25)00222-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Pages S28-S29\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425002229\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425002229","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
27P: Impact of platinum-based chemotherapy (CT) on acquired resistance (AR) to first-line immunecheckpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC): Individual patient data metanalysis
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.